Spyre Therapeutics (SYRE) total debt

Total debt · fiscal 2022
$4.63M

Only 1 fiscal year of total debt is on record here for Spyre Therapeutics (SYRE); a history needs at least 3. Figures as of 18 Nov 2026, 06:21 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2022
$4.63M
Fiscal years on record
12022–2022

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Not enough data

A history of total debt needs at least 3 fiscal years; one is on record here for Spyre Therapeutics. Nothing is estimated to fill the gap. What is on record is in the table below.

Spyre Therapeutics total debt, year by year

Spyre Therapeutics (SYRE) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2022$4.63M—0.1×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

Total debt at health care companies of similar size

Total debt of Spyre Therapeutics and comparable companies
CompanyTotal debtFiscal year
Vaxcyte PCVX$117.48M2025
Bio-Rad Laboratories BIO$1.39B2025
Molina Healthcare MOH$3.95B2025
Spyre Therapeutics SYRE$4.63M2022
Qiagen QGEN$1.81B2025
Insulet PODD$949.20M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on SYRE

Spyre Therapeutics, figure by figure

Spyre Therapeutics (SYRE) overview: price, valuation and scorecardAll health care companies by market value

Spyre Therapeutics total debt: questions and answers

How is Spyre Therapeutics's total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Spyre Therapeutics (SYRE) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/SYRE/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.